Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Kalmar outsources part of its crane engineering operations in China to Etteplan – Etteplan opens its ninth office in China to Taicang

Etteplan press release December 21, 2020 at 8.00 Etteplan and Kalmar, part of Cargotec, have agreed on the outsourcing of part of Kalmar’s crane engineering operations in China and the transfer of approximately 70 Kalmar’s engineering employees to Etteplan. The deal covers Kalmar’s crane engineering operations in Taicang and Shanghai and will become effective on January 1, 2021. Measured by the number of people, the deal is among the largest outsourcing agreements in Etteplan’s history and also marks the opening of Etteplan’s ninth office in China. With the planned long-term agreement

Fabege first with 100 per cent green financing

Fabege has achieved an important milestone in its sustainability work as all of the company’s loan agreements are now green. Therefore, Fabege is first among the Swedish property companies to exclusively choose green financing.With total borrowing of SEK 26 billion (as of 30 September 2020), Fabege is one of Sweden’s largest borrowers and can thus contribute to a greener financial market by setting a good example. Green financing provides an more robust loan portfolio that handles crises better as well as trusting relationships with creditors and, in addition, lower financing costs. “We

MEDIA STATEMENT BY STENALINE – 20[TH] DECEMBER, 2020 23:00

Important update for passengers intending to travel with Stena Line’s ferry services to the Republic of Ireland and the Netherlands.Due to new measures imposed by the Irish Government and the Government of the Netherlands, there are restrictions on passenger travel into both countries from the UK. Republic of Ireland For at least the next 48 hours from midnight tonight, passenger travel is not permitted on our services from the UK into the Republic of Ireland. Except for essential supply chain workers. This affects our Holyhead to Dublin and our Fishguard to Rosslare services. The

Chairman of the Board Maria Wasing declines re-election at the 2021 Annual General Meeting

Stockholm, Sweden—December 20, 2020— The Chair of the Board of Directors of I.A.R. Systems Group AB, Maria Wasing, has today informed the Nomination Committee that she declines re-election at the 2021 Annual General Meeting. “I want to be able to spend more time on my operational role as COO / vice president at Axiell, as well as developing companies I have active investments in. I am proud to have been a part of IAR Systems during a period where the company broadened its offering from software tools and services for embedded systems to also include advanced security solutions with a

Primary insider disclosure

The following primary insiders (or their related parties as described below) have, as part of the company's incentive program, committed to acquire shares in Ocean Yield ASA (the "Company" or "Ocean Yield"): · Lars Solbakken, CEO of Ocean Yield ASA, has through his wholly owned company Finmarine AS acquired 30,000 shares in Ocean Yield. Upon completion of such acquisition, Lars Solbakken will own, directly or indirectly, 1,700,880 shares in the Company. ·  Marius Magelie, SVP Finance & Investor Relations, has through his wholly owned company MGM Invest AS committed to acquire 7,000

Invitation to Q&A session about Castellum’s increased offer for Entra and the sale of warehouse and logistics properties

Welcome to a digital Q&A session on Monday 21 December at 09:00 am (CET).Due to the publication of the increased share exchange and cash offer to Entra’s shareholders and the sale of a mature stabilized asset portfolio, Castellum invites investors, analysts and journalists to a Q&A session. The session will be hosted by CEO Henrik Saxborn and CFO Ulrika Danielsson. Please register by the following link to participate:https://tv.streamfabriken.com/castellum-press-conference-21-december-2020 

Immunological analysis of Phase IIb trial with Diamyd[®] show differences between genetically defined patient groups

The first immunological results from DIAGNODE-2 show that the the immune response differs significantly between genetically defined patient groups for several immunological parameters following treatment with the diabetes vaccine Diamyd[® ] (GAD-alum). The results are in line with the earlier observed difference in clinical response (announced in September 2020) between individuals positive or negative for HLA type DR3-DQ2. DIAGNODE-2 is a placebo-controlled Phase IIb trial, where Diamyd[®] was injected directly into a lymph node in individuals recently diagnosed with type 1 diabetes.The

Eysturoy tunnel built by NCC opened in Faroe Islands

The Eysturoy tunnel, constructed by NCC for the customer P/E Eystur- og Sandoyartunlar (EST), was formally opened on Saturday. The 11.2 km subsea tunnel represents a significant infrastructure investment, which will reduce travel time to the capital city of Tórshavn from many places in the Faroe Islands. Photo: Estunlar.fo  “NCC congratulates all the people of the Faroe Islands and the company EST on the opening of the tunnel. As the main contractor, we are delighted to deliver, according to schedule, the first of two tunnels that will make life easier for the inhabitants of

Integrum AB granted PMA (premarket approval) by the FDA for the OPRA[™]Implant System

Integrum is both extremely pleased, and proud, to announce the PMA approval issued by the Food and Drug Administration (FDA) in the US for the OPRA[TM] Implant System as a class III medical device.   Integrum is both extremely pleased, and proud, to announce the PMA approval issued by the Food and Drug Administration (FDA) in the US for the OPRA[TM] Implant System as a class III medical device. In a release posted by FDA today, the agency stated: “Today’s approval of the OPRA Implant System expands options for prostheses for individuals who have had above-the-knee

Componenta Corporation resolved on adjustments to share-based incentive plans due to the rights issue and reverse share split

Componenta Corporation, Stock Exchange Release, 18 December at 21:30 The Board of Directors of Componenta Corporation has today, 18 December 2020, resolved on adjustments to the company’s share-based incentive plans. These adjustments are based on the rights issue the final results of which were announced on 9 December 2020, and on the reverse share split executed today, 18 December 2020. Adjustment to the Terms and Conditions of Stock Options 2018 The Board of Directors of Componenta Corporation announced the issue of stock options 2018 on 12 November 2018. Due to the rights issue

Componenta Corporation has executed a reverse share split

Componenta Corporation, Stock Exchange Release, 18 December at 21:30Componenta Corporation (”Componenta” or ”Company”) has today, 18 December 2020, on the previously announced reverse split date executed a reverse share split and thereto related directed share issue without consideration, redemption of shares and cancellation of shares. After these measures, the new number of shares in the Company is 9,492,444. The new number of shares has been registered with the Trade Register today on 18 December 2020, and trading with the merged shares commences on Monday 21 December with a new ISIN

IRLAB Therapeutics carries out a directed share issue in the amount of SEK 130,000,000

This press release may not be made public, published or distributed, directly or indirectly, within or to the United States, Australia, Hong Kong, Japan, Canada, New Zealand, Switzerland, Singapore, South Africa or any other jurisdiction where such action would be unlawful or subject to legal restrictions. Please see additional information at the end of this press release.The Board of Directors of IRLAB Therapeutics AB ("IRLAB" or the "Company") has based on the authorisation granted by the Annual General Meeting on 7 May 2020, resolved on a directed issue of 3,250,000 shares of class A at

Pomegranate Investment AB (publ) Releases Financial Report for the period of 6 months ended October 31, 2020.

NOT FOR DISTRIBUTION IN THE UNITED STATES OR TO ANY U.S. PERSONHighlight of the reporting period · The net asset value of the Company was EUR 123.2 mln as per October 31, 2020 corresponding to EUR 22.8 per share, compared with NAV per share of EUR 21.9 as per April 30, 2020. · Digikala achieved 168% growth in NMV in the first half of Iranian year 1399 compared with same period in the previous year, all while maintaining positive adjusted EBITDA. It also recorded the highest ever number of monthly orders at – 2 million. · Iranian stock market has experienced a correction in

CEO divests 10 percent of his shareholding in TF Bank to the chairman of the board

TF Bank AB (publ) has been informed that the company’s CEO Mattias Carlsson has sold about 10 percent of his shareholding, corresponding to 32,500 shares, in TF Bank to the company’s chairman of the board John Brehmer.Mattias Carlsson has sold the shares to repay loans. Following the sale, his holding amounts to 261,651 shares (directly and through a company). John Bremer’s holding amounts to 3,211,791 shares (through a company) following the purchase. The transaction took place at a price of SEK 89 per share. Information about the transaction will be published in the SFSA’s PDMR

TI condemns fake news campaign in Nigeria

Berlin, 16 December 2020  - Transparency International condemns the meritless false accusations made against it by groups in Nigeria and promoted by certain media outlets.  In Nigeria and around the world, Transparency International campaigns for a more just and fair society for all through the eradication of the scourge of corruption. Accusations that TI engages in blackmail, falsification of evidence and bribery are slanderous and defamatory. We condemn them absolutely. Delia Ferreira Rubio, Chair of Transparency International, said: “This pedalling of false accusations against

Multiconsult signs a call-off under the Fornebubanen frame agreement

Multiconsult (Oslo: MULTI) has signed an extension of multiple call-offs under the Fornebubanen frame agreement. The work starts in January 2021 and will last for a period of 2 - 3 years. The value of the call-off is approximately NOK 250 million for Multiconsult.Reference is made to the stock market announcement on 1 September 2017, where Multiconsult announced a frame agreement award with Oslo kommune for Fornebubanen. Multiconsult, with 50 % in a joint venture with Cowi, provides engineering services from pre-design until the completion of infrastructure, as well as any subsequent

UNITED BANKERS CORPORATION: ACQUISITION OF OWN SHARES 18.12.2020

United Bankers Corporation NOTIFICATION 18.12.2020 at 18:30 UNITED BANKERS CORPORATION: ACQUISITION OF OWN SHARES 18.12.2020 Date 18.12.2020Exchange transaction BuyShare class UNIAVAmount 592Average price/share 10.0000 EURHighest price/share 10.0000 EURLowest price/share 10.0000 EURTotal price 5,920.00 EUR The shares held by United Bankers Corporation on 18.12.2020: UNIAV 36,788   On behalf of United Bankers Corporation  Skandinaviska Enskilda Banken AB (Publ) Antti

Nasdaq Stockholm approves SSM’s application for delisting of SSM’s shares

On December 17, 2020, SSM Holding AB (”SSM”) announced through a press release that SSM’s board of directors has applied for delisting of SSM’s shares from Nasdaq Stockholm. On December 18, 2020, Nasdaq Stockholm has approved such application for delisting and has decided that the last day of trading of SSM’s shares will be January 7, 2021.  For more information, please contact:Ann-Charlotte JohanssonEVP Communications & IREmail: ann-charlotte.johansson@ssmliving.sePhone: +46 761 65 17 71  About SSM Holding ABSSM produces smart, affordable homes with attractive shared

Stayble resolves on a rights issue in order to ensure the completion of the ongoing phase 2b study

Stayble Therapeutics AB (“Stayble” or “the Company”) announces that the Board of Directors, with support of the authorization from the Annual General Meeting in 2019, has resolved on a new issue of shares in which the public is also given the opportunity to participate . The rights issue can provide the Company with a maximum of approximately SEK 41.5 million before issue costs. Prior to the rights issue, existing shareholders and external investors have entered subscription commitments totalling approximately SEK 19.8 million (corresponding to approximately 48 percent of the rights issue).

Aker Carbon Capture and Haldor Topsoe to cooperate on low-carbon hydrogen solutions

Aker Carbon Capture and Haldor Topsoe have signed a memorandum of understanding with the intention to offer a complete solution for low-carbon hydrogen production.The solution combines Haldor Topsoe’s proven hydrogen process and Aker Carbon Capture’s post combustion carbon capture technology to achieve low-emission and cost-effective production of ‘blue’ hydrogen – a clean energy carrier with a wide array of applications in industry and as a fuel. The European Union foresees investments of €11 billion for retrofitting half of the existing European hydrogen plants with carbon capture and

SAS SIGNS NOK 1.5 BILLION TERM LOAN FACILITY AGREEMENT

SAS AB (publ) (“SAS”) has signed a NOK 1.5 billion three-year term loan facility agreement, 100% guaranteed by the Norwegian Export Credit Guarantee Agency (GIEK). Since the Norwegian government announced credit guarantees to airlines, SAS has worked with four Nordic banks as well as GIEK to clarify the criteria and terms for the guarantees. The guarantee scheme, which has been approved by the EFTA Surveillance Authority and the Norwegian Parliament, was implemented in the context of the COVID-19 pandemic and is intended to support the airline’s liquidity to ensure airline operations in

The sale of the projects Ranasjö- and Salsjöhöjden is postponed

Arise AB (publ) (“Arise”) hereby announces that the planned sale of the projects Ranasjö- and Salsjöhöjden (the “Projects”) is postponed. This means that an application concerning a permit prolongation for one of the projects needs to be submitted. The ambition is to realise the Projects at a later stage. “We were hoping to realise the projects now but unfortunately this was not possible. I would like to thank all our partners in the project for all their efforts”, says Daniel Johansson, CEO Arise AB.Halmstad 18 December, 2020ARISE AB (publ)For further information, please contact

Letter from the CEO: Great progress in 2020 - we are ready for 2021!

Dear shareholder in Scandion Oncology, dear subscriber to Scandion Oncology News, At the cusp of the year 2020, and with almost 90 days for me as CEO, we can look back on a year in which Scandion Oncology entered two programs in clinical development with our lead candidate SCO-101 and we have thereby established the cornerstones in the strategic direction to become The Cancer Drug Resistance Company or said in other words: the company developing the first drugs that can revert resistance towards chemotherapy.As you are aware, this week, Scandion Oncology announced the results of the

There are no items matching the current filter
There are no more items matching the current filter
Back to top